Additionally, immunofluorescent staining of GSDMD, caspase‐1, and IL‐1β with Iba‐1 generated another line of evidence for enhanced microglial pyroptosis following stroke, whereas A151 treatment significantly suppressed such an increase (Fig 3D and E). The gene discussed is GSDMD; the disease is Stroke.